Delivery Order SPE2DB20D1100-SPE2DB24FC9D8

Award Date 7/25/24
Potential Completion Date 7/26/24
Potential Value $1.3K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $1,446.68, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Valacyclovir HCL 1 gram tablets in 90-count packages. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of August 22, 2024. The award was not designated under any set-aside program, indicating open...
This federal contract award is for pharmaceutical and medical supply delivery orders placed by the Defense Logistics Agency (DLA) with AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,978.26 firm fixed-price contract covers the delivery of Valtrex 1 GM caplets for the period through February 6, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,379.49 firm fixed-price delivery order is for the supply of 90-count packages of the generic drug Valacyclovir HCL 1 gram tablets. The contract has an ultimate completion date of March 12, 2025 and is not designated as a set-aside. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $1,200.62, is for the delivery of Valacyclovir HCL 1 gram tablets in 90-count packages. The contract is a Firm Fixed Price Delivery Order, with an ultimate completion date of April 2, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,024.62 firm-fixed-price delivery order is for Valacyclovir HCL 1 gram tablets in quantities of 90. The contract has no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc., which holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with...
This federal contract award is for the delivery of Valacyclovir HCL 1 gram tablets to the Defense Logistics Agency (DLA) Troop Support Medical. The award, valued at $6,189.34, was made to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. This contract is a delivery order under Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA, valued at up to $999,999,999.00 and running through November 2026. The IDC serves as the...
This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The $1,062.41 firm fixed price delivery order is for the supply of the pharmaceutical drug Valacyclovir Hydrochl. This order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, with a potential...
This federal contract award, valued at $1,698.37, was issued by the Defense agency Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the delivery of the pharmaceutical product Valacyclovir Hydrochloride, with a performance period ending on July 2, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a significant Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 with DLA...
This federal contract award, with ID SPE2DB20D7066|SPE2DB25FC2CG, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 90-count tablets of the antiviral medication Valacyclovir Hydrochloride 1 gram. The contract has a firm fixed price of $1,710.78 and an ultimate completion date of January 21, 2025. AmerisourceBergen holds a significant Indefinite Delivery...
This is a delivery order under contract SPE2DB24FVJD4 awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $4,114.70, is for the delivery of 30-count packages of the medication Valacyclovir HCL 1 gram tablets. This is a firm fixed-price, non-set-aside contract with a completion date of July 30, 2024. AmerisourceBergen holds several Indefinite Delivery Contracts (IDCs) with DLA Troop Support Medical and the...
  • SPE2DB20D1100
    Indefinite Delivery Contract
  • SPE2DB20D1100-SPE2DB24FC9D8
    Delivery Order

This federal contract award, valued at $1,262.01, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of 90 tablets of Valacyclovir HCl 1 gram, a medication used to treat viral infections. The contract is a Firm Fixed Price Delivery Order with a completion date of July 26, 2024.

AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, which covers similar medical products and prescription drugs. These IDCs enable efficient government procurement of essential pharmaceutical and medical supplies, serving the healthcare needs of military personnel, veterans, and other federal beneficiaries.

Generated 5/17/25, 9:53 AM